Marksans Pharma Ltd Share Price
(MARKSANS)
₹214.66▲0.21%
as on 04:01PM, 23 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -5.9 % |
3 Month Return | -15.02 % |
1 Year Return | + 27.66 % |
Market Stats | |
Previous Close | ₹214.21 |
Open | ₹215.99 |
Volume | 8.08L |
Upper Circuit | ₹257.05 |
Lower Circuit | ₹171.36 |
Market Cap | ₹9,727.61Cr |
P/E Ratio
26.4
PEG Ratio
27.5
Market Cap
₹9,727.61 Cr
P/B Ratio
5.62
EPS
6.95
Dividend Yield
0.4
Sector
Pharmaceuticals
ROE
11.46
based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 3 analysts offering long term price targets for Marksans Pharma. An average target of ₹299.33
Source: S&P Global Market Intelligence
Marksans Pharma price forecast by 3 analysts
Upside of39.44%
High
₹323
Target
₹299.33
Low
₹265
Marksans Pharma target price ₹299.33, a slight upside of 39.44% compared to current price of ₹214.66. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Marksans Pharma revenue growth forecast
Expected growth rate Q1, FY2027:64.00%
Forecast
Actual
Including amortisation and stock based compensations
Marksans Pharma EPS growth forecast
EPS estimate Q1, FY2027:94.36%
Forecast
Actual
Source: S&P Global Market Intelligence
Marksans Pharma Gains TGA Approval for Goa Facility - 20 Mar, 2025
Marksans Pharma Secures Baclofen Approval in UK - 19 Mar, 2025
Marksans Pharma Credit Rating Upgraded - 05 Mar, 2025
Marksans Pharma Gains UK Approval for Pain Relief Tablets - 25 Feb, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 4 quarters, 78.29 Cr → 104.56 Cr (in ₹), with an average increase of 9.2% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 11.07% to 11.32% in Mar 2025 quarter
Revenue Rich
Revenue is up for the last 4 quarters, 576.54 Cr → 709.7 Cr (in ₹), with an average increase of 6.7% per quarter
Best in 3 Years
In the last 3 years, MARKSANS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
MF Holding Up
Mutual Funds have increased holdings from 3.15% to 3.37% in Mar 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 56.9% return, outperforming this stock by 30.7%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 43.87% of holdings in Mar 2025 quarter
Price Dip
In the last 1 month, MARKSANS stock has moved down by -6.1%
Retail Holding Down
Retail Investor have decreased holdings from 29.87% to 29.37% in Mar 2025 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 43.87% | 0.00 | |
Foreign Institutions | 11.32% | 0.00 | |
Mutual Funds | 3.37% | 0.00 | |
Retail Investors | 29.37% | 0.00 | |
Others | 12.07% | 0.00 |
Marksans Pharma in the last 5 years
Lowest (4.67x)
April 1, 2020
Today (26.40x)
April 23, 2025
Industry (53.87x)
April 23, 2025
Highest (46.60x)
January 24, 2018
Marksans Pharma Ltd’s net profit jumped 25.61% since last year same period to ₹104.56Cr in the Q3 2024-2025. On a quarterly growth basis, Marksans Pharma Ltd has generated 8.11% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Marksans Pharma Ltd has declared dividend of ₹0.60 - translating a dividend yield of 0.51%.
Read More about DividendsBearish
Neutral
Bullish
Marksans Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹9,727.61 Cr | 188.41% | 0.51 | ₹314 Cr | ₹2,177 Cr | |
NA | ₹11.15 Cr | 66.72% | 0.50 | NA | NA | |
NA | ₹2,987.44 Cr | 39.26% | 0.53 | ₹96 Cr | ₹1,690 Cr | |
NA | ₹520.52 Cr | 260.56% | 0.73 | ₹7 Cr | ₹1 Cr | |
NA | ₹157.93 Cr | 105.19% | 0.69 | NA | NA |
Organisation | Marksans Pharma |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Marksans Pharma Ltd share price today stands at ₹214.66, Open: ₹215.99, Previous Close: ₹214.21, High: ₹219.13, Low: ₹212.1, 52 Week High: ₹358.7, 52 Week Low: ₹130.
Today's traded volume of Marksans Pharma Ltd(MARKSANS) is 8.08L.
Today's market capitalisation of Marksans Pharma Ltd(MARKSANS) is ₹9727.61Cr.
Marksans Pharma Ltd (MARKSANS) share price is ₹214.66. It is down -40.16% from its 52 Week High price of ₹358.7
Marksans Pharma Ltd (MARKSANS) share price is ₹214.66. It is up 65.12% from its 52 Week Low price of ₹130